404Switching from Posaconazole (POSA) Suspension to Tablets in Patients with Hematologic Malignancy Results in Increased Serum Levels but no Hepatotoxicity. (December 2014) - Jung, Dong Sik; Tverdek, Frank; Ponce, Francisco; Zhu, Yunlu; Kontoyiannis, Dimitrios